AU2001242749A1 - Peptide derivative - Google Patents
Peptide derivativeInfo
- Publication number
- AU2001242749A1 AU2001242749A1 AU2001242749A AU4274901A AU2001242749A1 AU 2001242749 A1 AU2001242749 A1 AU 2001242749A1 AU 2001242749 A AU2001242749 A AU 2001242749A AU 4274901 A AU4274901 A AU 4274901A AU 2001242749 A1 AU2001242749 A1 AU 2001242749A1
- Authority
- AU
- Australia
- Prior art keywords
- function regulator
- regulator
- development
- present
- peptide derivative
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 3
- 230000006870 function Effects 0.000 abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000004217 heart function Effects 0.000 abstract 1
- 230000036737 immune function Effects 0.000 abstract 1
- 239000003446 ligand Substances 0.000 abstract 1
- 230000007102 metabolic function Effects 0.000 abstract 1
- 210000005036 nerve Anatomy 0.000 abstract 1
- 230000007935 neutral effect Effects 0.000 abstract 1
- 210000000056 organ Anatomy 0.000 abstract 1
- 210000004798 organs belonging to the digestive system Anatomy 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 238000001525 receptor binding assay Methods 0.000 abstract 1
- 102000005962 receptors Human genes 0.000 abstract 1
- 108020003175 receptors Proteins 0.000 abstract 1
- 238000012216 screening Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Diabetes (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Toxicology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Gastroenterology & Hepatology (AREA)
- Endocrinology (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- AIDS & HIV (AREA)
- Vascular Medicine (AREA)
- Tropical Medicine & Parasitology (AREA)
- Reproductive Health (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2000087114 | 2000-03-23 | ||
| JP2000-87114 | 2000-03-23 | ||
| JP2000288891 | 2000-09-19 | ||
| JP2000-288891 | 2000-09-19 | ||
| PCT/JP2001/002278 WO2001070769A1 (fr) | 2000-03-23 | 2001-03-22 | Derive peptidique |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2001242749A1 true AU2001242749A1 (en) | 2001-10-03 |
Family
ID=26588465
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2001242749A Abandoned AU2001242749A1 (en) | 2000-03-23 | 2001-03-22 | Peptide derivative |
Country Status (10)
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003063892A1 (fr) * | 2002-01-29 | 2003-08-07 | Takeda Chemical Industries, Ltd. | Utilisation d'apeline |
| US8673848B2 (en) | 2012-01-27 | 2014-03-18 | Novartis Ag | Synthetic apelin mimetics for the treatment of heart failure |
| JPWO2007072980A1 (ja) * | 2005-12-20 | 2009-06-04 | 武田薬品工業株式会社 | アペリンの新規用途 |
| RU2303454C1 (ru) * | 2006-06-22 | 2007-07-27 | Общество С Ограниченной Ответственностью "Сиа Пептайдс" | Средство, нормализующее репродуктивную функцию у женщин, и способ его получения |
| EP1903052A3 (en) * | 2006-07-28 | 2008-04-02 | Faust Pharmaceuticals SA | APJ receptor ligands and uses thereof |
| WO2013050441A1 (en) | 2011-10-05 | 2013-04-11 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods and pharmaceutical composition for inhibiting or preventing platelet aggregation |
| WO2013079487A1 (en) | 2011-11-28 | 2013-06-06 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Pharmaceutical composition for use in the treatment of dysfunction associated with aging |
| CA2860740A1 (en) * | 2012-01-09 | 2013-07-18 | Anchor Therapeutics, Inc. | Apj receptor compounds |
| UY35144A (es) | 2012-11-20 | 2014-06-30 | Novartis Ag | Miméticos lineales sintéticos de apelina para el tratamiento de insuficiencia cardiaca |
| US8921307B2 (en) | 2012-11-20 | 2014-12-30 | Novartis Ag | Synthetic linear apelin mimetics for the treatment of heart failure |
| EP2935311B1 (en) | 2012-12-20 | 2021-03-31 | Amgen Inc. | Apj receptor agonists and uses thereof |
| TW201518323A (zh) | 2013-07-25 | 2015-05-16 | Novartis Ag | 合成ａｐｅｌｉｎ多肽之生物結合物 |
| AU2014293386B2 (en) | 2013-07-25 | 2016-11-17 | Novartis Ag | Cyclic polypeptides for the treatment of heart failure |
| CN104436158A (zh) * | 2013-09-22 | 2015-03-25 | 华中科技大学 | Apelin-13在治疗糖尿病肾病中的应用 |
| GB201407532D0 (en) * | 2014-04-29 | 2014-06-11 | Univ Ulster | Apelin analogues |
| PE20171328A1 (es) | 2015-01-23 | 2017-09-12 | Novartis Ag | Conjugados de acidos grasos y apelina sintetica con mayor vida media |
| EP3273981B1 (en) | 2015-03-24 | 2020-04-29 | INSERM - Institut National de la Santé et de la Recherche Médicale | Method and pharmaceutical composition for use in the treatment of diabetes |
| EA034776B1 (ru) | 2015-05-20 | 2020-03-19 | Эмджен Инк. | Триазоловые агонисты рецептора apj |
| WO2017140684A2 (en) | 2016-02-15 | 2017-08-24 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods and pharmaceutical compositions for the treatment of post-operative cognitive dysfunction |
| EP3452466B1 (en) | 2016-05-03 | 2020-08-12 | Amgen Inc. | Heterocyclic triazole compounds as agonists of the apj receptor |
| US11020395B2 (en) | 2016-11-16 | 2021-06-01 | Amgen Inc. | Cycloalkyl substituted triazole compounds as agonists of the APJ receptor |
| US11046680B1 (en) | 2016-11-16 | 2021-06-29 | Amgen Inc. | Heteroaryl-substituted triazoles as APJ receptor agonists |
| EP3541803B1 (en) | 2016-11-16 | 2020-12-23 | Amgen Inc. | Triazole pyridyl compounds as agonists of the apj receptor |
| WO2018093576A1 (en) | 2016-11-16 | 2018-05-24 | Amgen Inc. | Alkyl substituted triazole compounds as agonists of the apj receptor |
| EP3541792B1 (en) | 2016-11-16 | 2020-12-23 | Amgen Inc. | Triazole furan compounds as agonists of the apj receptor |
| US10906890B2 (en) | 2016-11-16 | 2021-02-02 | Amgen Inc. | Triazole phenyl compounds as agonists of the APJ receptor |
| EP3704122B1 (en) | 2017-11-03 | 2021-09-01 | Amgen Inc. | Fused triazole agonists of the apj receptor |
| MA52487A (fr) | 2018-05-01 | 2021-03-10 | Amgen Inc | Pyrimidinones substituées en tant qu'agonistes du récepteur apj |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK0630405T3 (da) * | 1992-11-17 | 1999-01-04 | Icos Corp | Hidtil ukendt 7-transmembranreceptor benævnt V28 |
| DE69838986T2 (de) * | 1997-12-24 | 2009-01-08 | Takeda Pharmaceutical Co. Ltd. | Polypeptide, deren herstellung und verwendung |
| US6475718B2 (en) * | 1998-09-08 | 2002-11-05 | Schering Aktiengesellschaft | Methods and compositions for modulating the interaction between the APJ receptor and the HIV virus |
| AU5759399A (en) * | 1998-09-25 | 2000-04-17 | Takeda Chemical Industries Ltd. | Peptide derivative |
-
2001
- 2001-03-22 WO PCT/JP2001/002278 patent/WO2001070769A1/ja active IP Right Grant
- 2001-03-22 US US10/239,321 patent/US7635751B2/en not_active Expired - Fee Related
- 2001-03-22 CA CA002403447A patent/CA2403447A1/en not_active Abandoned
- 2001-03-22 AT AT01915695T patent/ATE326478T1/de not_active IP Right Cessation
- 2001-03-22 EP EP01915695A patent/EP1270585B1/en not_active Expired - Lifetime
- 2001-03-22 AU AU2001242749A patent/AU2001242749A1/en not_active Abandoned
- 2001-03-22 KR KR1020027012331A patent/KR20020081466A/ko not_active Withdrawn
- 2001-03-22 CN CN01807077A patent/CN1419563A/zh active Pending
- 2001-03-22 DE DE60119714T patent/DE60119714T2/de not_active Expired - Lifetime
- 2001-03-23 JP JP2001084010A patent/JP4786047B2/ja not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP1270585A1 (en) | 2003-01-02 |
| WO2001070769A1 (fr) | 2001-09-27 |
| ATE326478T1 (de) | 2006-06-15 |
| EP1270585B1 (en) | 2006-05-17 |
| CN1419563A (zh) | 2003-05-21 |
| DE60119714T2 (de) | 2006-09-07 |
| KR20020081466A (ko) | 2002-10-26 |
| DE60119714D1 (de) | 2006-06-22 |
| JP2002167397A (ja) | 2002-06-11 |
| JP4786047B2 (ja) | 2011-10-05 |
| US7635751B2 (en) | 2009-12-22 |
| CA2403447A1 (en) | 2001-09-27 |
| US20040116336A1 (en) | 2004-06-17 |
| EP1270585A4 (en) | 2004-12-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2001242749A1 (en) | Peptide derivative | |
| WO2000034317A3 (en) | Method for reducing immunogenicity of proteins | |
| AU4162400A (en) | Derivatives of the b or z domain from staphylococcal protein a (spa) interactingwith at least one domain of human factor viii | |
| ATE522610T1 (de) | Menschliche, metabotrope glutamatrezeptor- subtypen (hmr6) und verwandte dns-verbindungen | |
| DK1005540T3 (da) | IKK-beta-proteiner, nukleinsyrer og fremgangsmåder | |
| AU5759399A (en) | Peptide derivative | |
| AU1208497A (en) | Ligand polypeptides for the g-protein-coupled receptor protein, their production and use | |
| WO2001064877A3 (en) | Human schizophrenia gene | |
| PT877803E (pt) | Receptor da proteina ob e composicoes e metodos afins | |
| DE68925275D1 (de) | Endotoxin-bindeprotein und dessen verwendung | |
| EP1005539A4 (en) | IKK-ALPHA PROTEINS, NUCLEIC ACIDS AND METHOD | |
| EP0992584A3 (en) | Purified mammalian FLT3 ligands and agonists and antagonists thereof | |
| EP0638067A4 (en) | NEW PROPOXYPHENE DERIVATIVES AND THEIR PROTEIN AND POLYPEPTIDE LABELS AND CONJUGATES. | |
| EP1208196A4 (en) | NEW SECRETINE FAMILY GPCR TYPE 15571 MOLECULE AND USES THEREOF | |
| EP0239311A3 (en) | Mutual separation of proteins | |
| EP0635016A4 (en) | BENZODIAZEPINE DERIVATIVES AND PROTEIN AND POLYPEPTIDE CONJUGATES OF SUCH DERIVATIVES. | |
| WO1999042127A3 (en) | Receptor derived peptides as modulators of receptor activity | |
| AU2003270010A1 (en) | Transferrin fusion protein libraries | |
| WO2001064876A3 (en) | Human schizophrenia gene | |
| EP0372503A3 (en) | Anticoagulant peptides | |
| AU5173996A (en) | Methadone derivatives and protein and polypeptide methadone derivative conjugates and labels | |
| NO992531L (no) | Fremgangsmåter ved fremstilling av rekombinant protein | |
| WO2004048549A3 (en) | Dep-1 receptor protein tyrosine phosphatase interacting proteins and related methods | |
| EP0926239A3 (en) | Beta-lipotropin and uses thereof | |
| WO1999041376A8 (en) | Retinoblastoma protein complexes and retinoblastoma interacting proteins |